VA

Vanitha Ayyappan

Active Director Designated Partner DIN 10991517
DIN 10991517 First appointment Mar 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Vanitha Ayyappan

Data last updated:

Vanitha Ayyappan is a Designated Partner at Sri Karpaga Vinayaka Super Speciality Hospital Llp (since 2025).

DIN 10991517
Primary Designation Designated Partner
First Appointment 08 Mar 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner08 Mar 20252025Active

Directorship timeline

Open interactive timeline →
Sri Karpaga Vinayaka Super Speciality Hospital Llp
Premium access

Shareholding and investment profile for Vanitha Ayyappan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vanitha Ayyappan

Vanitha Ayyappan currently holds 1 directorship: Sri Karpaga Vinayaka Super Speciality Hospital Llp (Designated Partner, since 08 Mar 2025).

Vanitha Ayyappan was first appointed on 08 Mar 2025 as Designated Partner at Sri Karpaga Vinayaka Super Speciality Hospital Llp.

The current boards of Vanitha Ayyappan's companies include Arumugam Vijayakumar (Sri Karpaga Vinayaka Super Speciality Hospital Llp), Balaji Divya (Sri Karpaga Vinayaka Super Speciality Hospital Llp), Naveensuresh C (Sri Karpaga Vinayaka Super Speciality Hospital Llp), Senthilkumar Muthusami (Sri Karpaga Vinayaka Super Speciality Hospital Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available